Hodgkin Lymphoma: Clinical Trials

148 trials for Hodgkin Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

50 completed, 29 recruiting, 24 unknown, 18 active not recruiting. 148 Phase 2, 27 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2148Completed 50, Recruiting 29, Unknown 24, Active not recruiting 18, Terminated 16, Not yet recruiting 5, Suspended 3, Withdrawn 3
Phase 127Completed 9, Recruiting 6, Active not recruiting 5, Terminated 3, Unknown 3, Not yet recruiting 1
Phase 32Recruiting 1, Unknown 1

Follow Hodgkin Lymphoma: new trials by email Literature Review of Hodgkin Lymphoma trials Research Report on Hodgkin Lymphoma

Trials (filtered) newest first · largest first

All 148 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
Fludarabine, Cyclophosphamide, CD70.CAR NK Cells - Large B-cell Lymphoma, Hodgkin Lymphoma
Phase 2Not yet recruitingM.D. Anderson Cancer Center1002026-12-282026-07-15
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
Phase 2Not yet recruitingFred Hutchinson Cancer Center502026-12-012026-09-17
Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
Nivolumab, Doxorubicin Hydrochloride, Vinblastine - Hodgkin Lymphoma
Phase 2RecruitingM.D. Anderson Cancer Center152026-08-192026-08-31
PD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma
PD-1+JAK1i, PD-1 - Hodgkin Lymphoma
Phase 1 / Phase 2Not yet recruitingShanghai Jiao Tong University School of Medicine1122026-06-302026-06-11
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Cord Blood Units, Total Body Irradiation, Cyclophosphamide - Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia
Phase 2RecruitingMemorial Sloan Kettering Cancer Center712026-04-282026-05-14
ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
Cyclophosphamide, Fludarabine, Thiotepa - Acute Myelogenous Leukemia, Acute Lymphatic Leukemia
Phase 2SuspendedLeland Metheny202026-04-082026-09-10
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Cancer Therapeutic Procedure, Questionnaire Administration - Amyloidosis, Basal Cell Carcinoma
Phase 2RecruitingMayo Clinic272025-12-182026-09-30
Mozobil for Autologous Hematopoietic Stem Cell Transplantation
Plerixafor, Gcsf - Multiple Myeloma, Hodgkin Lymphoma
Phase 2SuspendedThomas Jefferson University1002025-10-162026-11-18
Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma
Pembrolizumab - Hodgkin Lymphoma
Phase 2Not yet recruitingUniversity of Cologne402025-08-012025-04-06
PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma
Nivolumab, N-EACOPD-14, N-AVD - Hodgkin Lymphoma, Hodgkin Disease
Phase 2RecruitingNational Research Center for Hematology, Russia302025-07-292025-10-06
BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma
Brentuximab Vedotin, Etoposide, Cyclophosphamide - Hodgkin Lymphoma, Advanced Hodgkin Lymphoma
Phase 2RecruitingUniversity of Miami482025-07-152026-11-18
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
VI-0609, BiCNU - Lymphoma, Non-Hodgkin Lymphoma
Phase 2RecruitingVIVUS LLC492025-03-122026-03-27
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
Cobolimab, Dostarlimab - Melanoma, Hodgkin Lymphoma
Phase 1 / Phase 2Active not recruitingGlaxoSmithKline832025-03-062025-11-12
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Riluzole, Placebo - Breast Cancer, Sarcoma
Phase 2RecruitingUniversity of California, Irvine752024-12-022026-07-14
Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL
Nivo-AVD, BEACOPP-like - Hodgkin Lymphoma
Phase 2RecruitingSt. Petersburg State Pavlov Medical University1782024-10-142026-04-01
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Granulocyte Colony-Stimulating Factor - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 2RecruitingCity of Hope Medical Center2162024-07-092026-10-23
PTCy and ATG for MSD and MUD Transplants
ATG 5.0, Cyclophosphamide injection, ATG 4.0 - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Phase 1 / Phase 2RecruitingInstituto Nacional de Cancer, Brazil502024-06-142025-02-25
Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy
Tislelizumab - Hodgkin Lymphoma
Phase 2RecruitingFondazione Italiana Linfomi - ETS282024-05-232026-08-19
ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
Chemotherapy, Cell infusion - Hodgkin Lymphoma, Relapse
Phase 1 / Phase 2RecruitingUNC Lineberger Comprehensive Cancer Center312024-04-252026-08-06
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Brentuximab vedotin, Doxorubicin, Vinblastine - Hodgkin Lymphoma
Phase 2RecruitingMemorial Sloan Kettering Cancer Center712024-04-172026-04-23

Showing 20 of 148. Sign in to see all of them.

Narrower conditions

Hodgkin Disease (148)  ·  Lymphoma, Non-Hodgkin (42)  ·  Myelodysplastic Syndromes (32)  ·  Leukemia, Myeloid, Acute (26)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (24)  ·  Multiple Myeloma (23)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (21)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (20)  ·  Lymphoma, Mantle-Cell (15)  ·  Myeloproliferative Disorders (15)  ·  Lymphoma (13)  ·  Lymphoma, Follicular (13)  ·  Lymphoma, Large B-Cell, Diffuse (12)  ·  Burkitt Lymphoma (10)  ·  Leukemia (9)

Broader conditions

Immune System Diseases (148)  ·  Immunoproliferative Disorders (148)  ·  Hemic and Lymphatic Diseases (147)  ·  Lymphatic Diseases (147)  ·  Lymphoproliferative Disorders (147)  ·  Neoplasms by Histologic Type (147)  ·  Neoplasms (145)  ·  Lymphoma (135)  ·  Hematologic Diseases (46)  ·  Pathological Conditions, Signs and Symptoms (42)  ·  Pathologic Processes (41)  ·  Disease Attributes (40)  ·  Bone Marrow Diseases (36)  ·  Leukemia, Lymphoid (34)  ·  Chronic Disease (32)

Interventions

Cyclophosphamide (32)  ·  Brentuximab Vedotin (24)  ·  Nivolumab (22)  ·  Doxorubicin (19)  ·  Mycophenolic Acid (19)  ·  Whole-Body Irradiation (18)  ·  fludarabine (16)  ·  pembrolizumab (16)  ·  Dacarbazine (14)  ·  Etoposide (12)  ·  Vinblastine (12)  ·  fludarabine phosphate (12)  ·  Granulocyte Colony-Stimulating Factor (11)  ·  Melphalan (11)  ·  Tacrolimus (10)

Sponsors

Memorial Sloan Kettering Cancer Center (10)  ·  M.D. Anderson Cancer Center (7)  ·  St. Jude Children's Research Hospital (6)  ·  University of Cologne (6)  ·  City of Hope Medical Center (5)  ·  St. Petersburg State Pavlov Medical University (5)  ·  Chinese PLA General Hospital (4)  ·  Fondazione Italiana Linfomi - ETS (4)  ·  Masonic Cancer Center, University of Minnesota (4)  ·  Fred Hutchinson Cancer Center (3)  ·  Massachusetts General Hospital (3)  ·  Merck Sharp & Dohme LLC (3)  ·  New York Medical College (3)  ·  Seagen Inc. (3)  ·  The Lymphoma Academic Research Organisation (3)

Countries

United States (91)  ·  Italy (14)  ·  China (13)  ·  France (10)  ·  Germany (9)  ·  Russia (8)  ·  Spain (7)  ·  Australia (6)  ·  Belgium (6)  ·  United Kingdom (6)  ·  Canada (5)  ·  Israel (5)  ·  Brazil (4)  ·  Czechia (4)  ·  Poland (4)

Top investigators

Alison Moskowitz, MD (4)  ·  Peter Borchmann, Prof. (4)  ·  Anas Younes, MD (2)  ·  Arnon Nagler, MD (2)  ·  Brandon Triplett, MD (2)  ·  Graham Collins (2)  ·  Jeremy Abramson, MD (2)  ·  Mitchell Cairo, MD (2)  ·  Natalia Mikhailova, MD (2)  ·  Ryotaro Nakamura, MD (2)  ·  Usama Gergis, MD (2)  ·  Alessandro Levis, PhD (1)  ·  Alexander Kulagin, MD,PhD (1)

Results publications

PMID 40135712, PMID 12377653, PMID 21841163, PMID 22735430, PMID 24573552, PMID 25482239, PMID 27269947, PMID 27760761, PMID 28327905, PMID 28441111, PMID 29141948, PMID 29229594, PMID 29276022, PMID 29360414, PMID 29774169, PMID 30952672, PMID 31012356, PMID 31039052, PMID 31186274, PMID 31395089, PMID 31409671, PMID 31471376, PMID 31917843, PMID 32040960, PMID 32946355, PMID 33062947, PMID 33171487, PMID 33674274, PMID 33820822, PMID 33827139, PMID 34156440, PMID 34327561, PMID 34568066, PMID 34670169, PMID 35848865, PMID 35867960, PMID 36053786, PMID 36399518, PMID 36409612, PMID 37130682, PMID 37319432, PMID 37319435, PMID 37505794, PMID 38454451, PMID 38517235, PMID 39093981, PMID 39319495, PMID 39620432, PMID 39622165, PMID 39661923

NIH funding

2017 (4), 2023 (3), 2014 (2), 2018 (2), 2005 (1), P01CA049605 (1), P01CA078902 (1), P30CA015704 (1), P30CA033572 (1), P30CA138292 (1), R01CA077544 (1), R01CA266783 (1)